Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Global Clinical Nutrition Products Strategic Busin

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 311)
Posted On: 04/19/2017 7:00:16 AM
Avatar
Posted By: News Desk 2018
Global Clinical Nutrition Products Strategic Business Report 2017-2022: Profiles of 65 Companies - Leading Companies are Abbott Nutrition, Danone, Fresenius Kabi & Nestle

Dublin, April 19, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Clinical Nutrition Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million. The Global market is analyzed by the following segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 65 companies including many key and niche players such as

  • Abbott Nutrition (US)
  • Baxter International, Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Claris Lifesciences Ltd. (India)
  • Claris Otsuka Private Ltd. (India)
  • Fresenius Kabi AG (Germany)
  • Groupe Danone (France)
  • Nutricia North America (US)
  • Huarui Pharmaceutical Co., Ltd. (China)
  • ICU Medical, Inc. (US)
  • Mead Johnson Nutrition Company (US)
  • Meiji Co., Ltd. (Japan)
  • Nestlé Health Science S.A (Switzerland)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)

Key Topics Covered: 1. INDUSTRY OVERVIEW

  • Clinical Nutrition Products: Essential for Addressing Disease -Related Malnutrition
  • Market Outlook
  • Developed Regions Lead, Emerging Markets to Spearhead Future Growth
  • Infant Nutrition Market: The Leading Segment with High Growth Potential
  • Need for Nutritional Support
  • Essential for Preterm Infants
  • Inadequate Physiological Development Raises Need for Tube Feeding in Infants
  • Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
  • Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
  • Asia-Pacific to Drive Future Growth in PN Products Market
  • Enteral Nutrition
  • Preferred Approach Compared to Parenteral Nutrition Products
  • Standard Enteral Nutrition Formulations Lead EN Products Market
  • Oncology Applications Leads EN Market
  • Hospitals & Long-term Care Facilities: The Major Users of EN Products

2. COMPETITIVE LANDSCAPE

  • A Highly Competitive Marketplace
  • Enteral Nutrition Market
  • Parenteral Nutrition Market

3. MARKET DRIVERS, TRENDS & ISSUES

  • Sustained Increase in Healthcare Spending Bodes Well for Clinical Nutrition Market
  • Aging Worldwide Population: Rising Need for Added Nutritional Support to Propel Market Growth
  • Rising Incidence of Chronic Diseases to Kindle Market Growth
  • Cancer
  • The Major Chronic Illness Requiring Clinical Nutrition Support
  • Critical Nutrition Products Vital for Preventing Malnutrition in Diabetics
  • Persistent Threat of HIV/AIDS Infection: An Opportunity for Medical Nutrition Market
  • Some Significant HIV Statistics by Region: 2015
  • Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
  • Non-volitional Nutritional Support Therapy: Vital for Combating Malnutrition during Hospitalization
  • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
  • Changing Health and Social Care Factors Favor Home Enteral Feeding
  • Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
  • Preterm Birth Statistics from WHO
  • Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
  • Product Innovations Blur the Lines between Medicine and Foods
  • Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
  • Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
  • Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
  • Specialized Formula Products Inundate the Market
  • Soy-based Infant Formula Gains Popularity
  • Pre-mixed IV Solutions: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Complacency of Hospitals & Worker/Patient Safety: A Key Issue
  • Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
  • Rising Preference for Enteral Nutrition
  • A Threat to Parenteral Nutrition Market
  • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
  • Major Challenges Confronting Medical Nutrition Products' Marketers
  • Barriers to Widespread Adoption of Clinical Nutrition Products
  • Reasons for Not Prescribing Clinical Nutrition Products

4. PRODUCT OVERVIEW

  • Clinical Nutrition: An Introduction
  • Diseases Indicating Administering of Clinical Nutrition
  • Advantages of Clinical Nutrition
  • Classification of Clinical Nutrition Products
  • Infant Nutrition Products
  • List of Infant Nutrition Products
  • Types of Infant Nutrition Products
  • Specialized Milk-Based Formulas
  • Soy-based Infant Formula
  • Amino Acid-based Formulas
  • Probiotic Infant Formulas
  • Prebiotics in Infant Nutrition
  • Exempt Infant Formulas
  • Human Milk Oligosaccharides
  • Nutrition Products for Preterm Infants
  • Premature Infant Formula
  • Transitional Formulas
  • Human Milk Fortifiers
  • Metabolic Infant Formulas
  • Follow-up or Follow-on Formulas
  • Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
  • Nipple Feeding
  • Tube Feeding
  • Enteral Nutrition Products
  • Enteral Nutrition by Age
  • Enteral Nutrition for Patients aged 21 and older
  • Enteral Nutrition for Patients below 21 Years
  • Various Types of Enteral Feeding or Tube Feeding
  • What Constitutes Enteral Nutrition Diets?
  • Home-Made Diets
  • Commercial Enteral Formulas
  • Elemental Formulas
  • Oligomeric Formulas
  • Polymeric Formulas
  • Special Formulas
  • Pulmonary Formulas
  • Liver Formulas
  • Renal Formulas
  • Diabetes Formulas
  • Gastrointestinal Dysfunction Formulas
  • Immuno-modulatory Formulas
  • Enteral Nutrition in Patients with Acute Renal Failure (ARF)
  • Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
  • Enteral Nutrition in Haemodialysis Patients
  • Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
  • Complications of Enteral Feeding
  • Complications Associated with Enteral Tube Feeding
  • Parenteral Nutrition
  • Sources of Parenteral Solutions
  • Routes of Administration
  • Types of Parenteral Nutrition Solutions
  • Total Parenteral Nutrition (TPN)
  • TPN Formulation
  • Partial Parenteral Nutrition (PPN)
  • Home Parenteral Nutrition
  • Parenteral Nutrition Formulations
  • Standard Solutions
  • Three-in-One Standard Bags
  • Two-in-one Standard Bags
  • Individual Solutions
  • Non-Standard Solutions
  • Classification of Parenteral Nutrition by Type of Nutrients
  • Amino Acids
  • Carbohydrates
  • Lipids
  • Minerals & Electrolytes
  • Micronutrients
  • Vitamins
  • Trace Elements
  • Large and Small Volume Parenteral Solutions
  • Large Volume Parenteral (LVP) Solutions
  • Small Volume Parenteral (SVP) Solutions
  • IV Fat Emulsions
  • Enabling Maintenance of Bodyweight

5. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Nestlé Health Science Introduces Compleat® Range of Tube- Feeding Formulas
  • Fresenius Kabi Unveils IVFE Smoflipid® for Adults
  • Otsuka Pharmaceutical Factory Gains Approval for ELNEOPA-NF Injection
  • B. Braun Medical Unveils Clinical Nutrition 360 TPN Portfolio
  • B. Braun Medical Introduces Nutrilipid® 20% for Parenteral Nutrition Therapy
  • Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
  • Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®
  • B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition

6. RECENT INDUSTRY ACTIVITY

  • ICU Medical Acquires Pfizer's Hospira Infusion Therapy Business
  • OP2Labs Acquires Provide Nutrition
  • Abbott and Vietnam's Ministry of Health Forge Strategic Partnership
  • Baxter International Gains Marketing Approval for NUMETA G13E PN Product
  • Nestlé Japan Acquires Ajinomoto's Tube Feeding Business
  • Linde Group Takes Over American HomePatient
  • Epic Health Services Takes Over Option 1 Healthcare Solutions
  • Baxter Inks Global Licensing and Distribution Agreement with Laboratoire Aguettant
  • Pfizer Acquires Hospira
  • Nestlé Sets Up Health Science Manufacturing Plant
  • Baxter Recalls Select Lots of Parenteral Nutrition Products
  • ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
  • Abbott Receives Approval for ENEVO Liquid for Enteral Use
  • Nestlé to Construct Infant Formula Plant in Mexico
  • Abbott Inaugurates Nutrition Production Facility in Haiti
  • Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
  • Baxter Collaborates with JW Holdings for Omega 3 Lipids
  • Mead Johnson Establishes New Manufacturing and Research & Development Complex

7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 65 (including Divisions/Subsidiaries 84)

  • The United States (27)
  • Canada (1)
  • Japan (5)
  • Europe (29)
  • - France (5)
  • - Germany (5)
  • - The United Kingdom (4)
  • - Italy (1)
  • - Spain (1)
  • Rest of Europe (13)
  • Asia-Pacific (Excluding Japan) (20)
  • Latin America (2)

For more information about this report visit http://www.researchandmarkets.com/research/kszhvf/clinical

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Hospital Management



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us